 | • レポートコード：MRC2206A031 • 出版社/出版日：Persistence Market Research / 2022年3月30日 • レポート形態：英文、PDF、344ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界の口腔乾燥症（口渇）治療市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、新型コロナウイルス感染症による危機分析、付加価値洞察、市場規模分析・予測、製品別（口腔スプレー、経口溶剤、経口液、ジェル、粉末）分析、年齢層別（小児、成人）分析、流通チャネル別（病院薬局、小売薬局、ドラッグストア、通信販売薬局、ハイパーマーケット＆スーパーマーケット）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しております。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場背景 ・新型コロナウイルス感染症による危機分析 ・付加価値洞察 ・市場規模分析・予測 ・世界の口腔乾燥症（口渇）治療市場規模：製品別（口腔スプレー、経口溶剤、経口液、ジェル、粉末） ・世界の口腔乾燥症（口渇）治療市場規模：年齢層別（小児、成人） ・世界の口腔乾燥症（口渇）治療市場規模：流通チャネル別（病院薬局、小売薬局、ドラッグストア、通信販売薬局、ハイパーマーケット＆スーパーマーケット） ・世界の口腔乾燥症（口渇）治療市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Xerostomia (Dry Mouth) Treatment Market: Scope of Report
The latest publication by Persistence Market Research on the global xerostomia (dry mouth) treatment market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for xerostomia (dry mouth) treatment products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the xerostomia (dry mouth) treatment market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the xerostomia treatment market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the xerostomia (dry mouth) treatment market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the dry mouth treatment market offers information divided into five important segments – product, age group, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Product
Oral Sprays
Oral Solutions
Oral Liquids
Gels
Powders
Age Group
Pediatric
Adult
Early Adults (18-34 Years)
Early Middle Age (35 – 44 Years)
Late Middle Age (45 – 64 Years)
Late Adulthood (Above 65+Years)
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Hypermarkets and Supermarkets
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for xerostomia treatment over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the dry mouth treatment market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the xerostomia (dry mouth) treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the xerostomia (dry mouth) treatment market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Background
4.1. Macro-Economic Factors
4.1.1. Global GDP Outlook
4.1.2. Increasing Spending on Healthcare Per Capita
4.1.3. High Spending on Oral Care Products
4.1.4. Supply Chain Model Issues
4.2. Forecast Factors – Relevance & Impact
4.2.1. GDP Growth
4.2.2. Increasing Investments in R&D Activities
4.2.3. High prevalence of xerostomia
4.2.4. Treatment Seeking Rate (%)
4.2.5. Disposable income
4.2.6. Average duration of treatment
4.2.7. Dosage Pattern (%)
4.2.8. Overall Treatment cost
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
5. COVID19 Crisis Analysis
5.1. Current COVID19 Probable Future Impact
5.2. COVID19 and Impact Analysis
5.2.1. Revenue by Product
5.2.2. Revenue by Age Group
5.2.3. Revenue by Distribution Channel
5.2.4. Revenue by Country
6. Value Added Insights
6.1. Disease Epidemiology
6.2. Regulatory Scenario
6.3. PESTLE Analysis
6.4. Porters Analysis
6.5. Key Promotional Strategies by Manufacturers
7. Global Xerostomia (Dry Mouth) Treatment Market Value (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.2. Current and Future Market Value (In Value or Size in US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (In Value or Size in US$ Mn) & Volume Trend, By Product, 2017-2021
8.3. Current and Future Market Size (In Value or Size in US$ Mn) & Volume Trend Analysis and Forecast, By Product, 2022-2032
8.3.1. Product
8.3.1.1. Oral Spray
8.3.1.2. Oral Solution
8.3.1.3. Oral Liquid
8.3.1.4. Gel
8.3.1.5. Powder
8.4. Market Attractiveness Analysis, By Product
9. Global Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Age Group
9.1. Introduction / Key Findings
9.2. Historical Market Size (In Value or Size in US$ Mn) Trend, By Age Group, 2017-2021
9.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast, By Age Group, 2022-2032
9.3.1. Pediatric
9.3.2. Adult
9.3.2.1. Early Adults (18-34)
9.3.2.2. Early Middle Age (35 – 44)
9.3.2.3. Late Middle Age (45 – 64)
9.3.2.4. Late Adulthood (Above 65+)
9.4. Market Attractiveness Analysis, By Age Group
10. Global Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (In Value or Size in US$ Mn) Trend, By End User, 2017-2021
10.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis and Forecast, By Distribution Channel, 2022-2032
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Drug Stores
10.3.4. Mail Order Pharmacies
10.3.5. Hypermarkets and Supermarkets
10.4. Market Attractiveness Analysis, By Distribution Channel
11. Global Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (In Value or Size in US$ Mn) Analysis, By Region, 2017-2022
11.3. Current Market Size (In Value or Size in US$ Mn) Analysis and Forecast, By Region, 2021 – 2031
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MIDDLE EAST & AFRICA)
11.4. Market Attractiveness Analysis, By Region
12. North America Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Historical Market Size (In Value or Size in US$ Mn Trend Analysis, By Market Taxonomy, 2017-2021
12.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast, By Market Taxonomy, 2022-2032
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Age Group
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Latin America Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis, By Market Taxonomy, 2017-2021
13.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast, By Market Taxonomy, 2022-2032
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Age Group
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Europe Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis, By Market Taxonomy, 2017-2021
14.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast, By Market Taxonomy, 2022-2032
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Age Group
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia and Pacific Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis, By Market Taxonomy, 2017-2021
15.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast, By Market Taxonomy, 2022-2032
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Age Group
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. East Asia Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis, By Market Taxonomy, 2017-2021
16.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast, By Market Taxonomy, 2022-2032
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Age Group
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Oceania Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis, By Market Taxonomy, 2017-2021
17.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast, By Market Taxonomy, 2022-2032
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Age Group
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Xerostomia (Dry Mouth) Treatment Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (In Value or Size in US$ Mn) Trend Analysis, By Market Taxonomy, 2017-2021
18.3. Current and Future Market Size (In Value or Size in US$ Mn) Trend Analysis Forecast, By Market Taxonomy, 2022-2032
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By Age Group
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Country Level Xerostomia (Dry Mouth) Treatment Market Analysis 2022 & 2032
19.1. Introduction
19.1.1. Market Value (US$ Mn) Proportion Analysis, By Country
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.2.1. By Product
19.2.2. By Age Group
19.2.3. By Distribution Channel
19.3. Canada Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.3.1. By Product
19.3.2. By Age Group
19.3.3. By Distribution Channel
19.4. Brazil Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.4.1. By Product
19.4.2. By Age Group
19.4.3. By Distribution Channel
19.5. Mexico Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.5.1. By Product
19.5.2. By Age Group
19.5.3. By Distribution Channel
19.6. Argentina Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.6.1. By Product
19.6.2. By Age Group
19.6.3. By Distribution Channel
19.7. Germany Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.7.1. By Product
19.7.2. By Age Group
19.7.3. By Distribution Channel
19.8. Italy Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.8.1. By Product
19.8.2. By Age Group
19.8.3. By Distribution Channel
19.9. France Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.9.1. By Product
19.9.2. By Age Group
19.9.3. By Distribution Channel
19.10. U.K. Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.10.1. By Product
19.10.2. By Age Group
19.10.3. By Distribution Channel
19.11. Spain Mexico Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.11.1. By Product
19.11.2. By Age Group
19.11.3. By Distribution Channel
19.12. BENELUX Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.12.1. By Product
19.12.2. By Age Group
19.12.3. By Distribution Channel
19.13. Russia Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.13.1. By Product
19.13.2. By Age Group
19.13.3. By Distribution Channel
19.14. India Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.14.1. By Product
19.14.2. By Age Group
19.14.3. By Distribution Channel
19.15. Thailand Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.15.1. By Product
19.15.2. By Age Group
19.15.3. By Distribution Channel
19.16. Indonesia Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.16.1. By Product
19.16.2. By Age Group
19.16.3. By Distribution Channel
19.17. Malaysia Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.17.1. By Product
19.17.2. By Age Group
19.17.3. By Distribution Channel
19.18. China Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.18.1. By Product
19.18.2. By Age Group
19.18.3. By Distribution Channel
19.19. Japan Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.19.1. By Product
19.19.2. By Age Group
19.19.3. By Distribution Channel
19.20. South Korea Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.20.1. By Product
19.20.2. By Age Group
19.20.3. By Distribution Channel
19.21. Australia Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.21.1. By Product
19.21.2. By Age Group
19.21.3. By Distribution Channel
19.22. New Zealand Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.22.1. By Product
19.22.2. By Age Group
19.22.3. By Distribution Channel
19.23. GCC Countries Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.23.1. By Product
19.23.2. By Age Group
19.23.3. By Distribution Channel
19.24. Turkey Xerostomia (Dry Mouth) Treatment Market Value (US$) Analysis
19.24.1. By Product
19.24.2. By Age Group
19.24.3. By Distribution Channel
19.25. South Africa Xerostomia (Dry Mouth) Treatment Market Value (US$) and Analysis
19.25.1. By Product
19.25.2. By Age Group
19.25.3. By Distribution Channel
20. Market Structure Analysis
20.1. Market Analysis, By Tier of Companies
20.2. Market Share Analysis of Top Players
20.3. Market Presence Analysis
20.3.1. Regional footprint of Players
20.3.2. Product foot print by Players
20.3.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. GlaxoSmithKline Plc
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Key Financials
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Product Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Daiichi Pharmaceutical Co., Ltd.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Key Financials
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Product Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Bausch Health Companies Inc. (OraPharma)
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Key Financials
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Product Strategy
21.3.3.5.3. Channel Strategy
21.3.4. ADVANZ PHARMA Corp. Limited
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Key Financials
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Product Strategy
21.3.4.5.3. Channel Strategy
21.3.5. CCMed Ltd.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Key Financials
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Product Strategy
21.3.5.5.3. Channel Strategy
21.3.6. Elevate Oral Care, LLC
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Key Financials
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Product Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Orahealth Corporation
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Key Financials
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Product Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Forward Science
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Key Financials
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Product Strategy
21.3.8.5.3. Channel Strategy
21.3.9. Parnell Pharmaceuticals, Inc
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Key Financials
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Product Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Cyclacel Pharmaceuticals, Inc.
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Key Financials
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Product Strategy
21.3.10.5.3. Channel Strategy
21.3.11. Midatech Pharma Plc.
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Key Financials
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Marketing Strategy
21.3.11.5.2. Product Strategy
21.3.11.5.3. Channel Strategy
21.3.12. Perrigo Company Plc.
21.3.12.1. Overview
21.3.12.2. Product Portfolio
21.3.12.3. Key Financials
21.3.12.4. Sales Footprint
21.3.12.5. Strategy Overview
21.3.12.5.1. Marketing Strategy
21.3.12.5.2. Product Strategy
21.3.12.5.3. Channel Strategy
21.3.13. Entod International
21.3.13.1. Overview
21.3.13.2. Product Portfolio
21.3.13.3. Key Financials
21.3.13.4. Sales Footprint
21.3.13.5. Strategy Overview
21.3.13.5.1. Marketing Strategy
21.3.13.5.2. Product Strategy
21.3.13.5.3. Channel Strategy
21.3.14. Laboratories Kin, SA
21.3.14.1. Overview
21.3.14.2. Product Portfolio
21.3.14.3. Key Financials
21.3.14.4. Sales Footprint
21.3.14.5. Strategy Overview
21.3.14.5.1. Marketing Strategy
21.3.14.5.2. Product Strategy
21.3.14.5.3. Channel Strategy
21.3.15. ICPA HEALTH PRODUCTS Ltd
21.3.15.1. Overview
21.3.15.2. Product Portfolio
21.3.15.3. Key Financials
21.3.15.4. Sales Footprint
21.3.15.5. Strategy Overview
21.3.15.5.1. Marketing Strategy
21.3.15.5.2. Product Strategy
21.3.15.5.3. Channel Strategy
21.3.16. Biocosmetic Laboratories
21.3.16.1. Overview
21.3.16.2. Product Portfolio
21.3.16.3. Key Financials
21.3.16.4. Sales Footprint
21.3.16.5. Strategy Overview
21.3.16.5.1. Marketing Strategy
21.3.16.5.2. Product Strategy
21.3.16.5.3. Channel Strategy
21.3.17. The 3M Company
21.3.17.1. Overview
21.3.17.2. Product Portfolio
21.3.17.3. Key Financials
21.3.17.4. Sales Footprint
21.3.17.5. Strategy Overview
21.3.17.5.1. Marketing Strategy
21.3.17.5.2. Product Strategy
21.3.17.5.3. Channel Strategy
21.3.18. Mission Pharmacal Company
21.3.18.1. Overview
21.3.18.2. Product Portfolio
21.3.18.3. Key Financials
21.3.18.4. Sales Footprint
21.3.18.5. Strategy Overview
21.3.18.5.1. Marketing Strategy
21.3.18.5.2. Product Strategy
21.3.18.5.3. Channel Strategy
21.3.19. Chattem, Inc. (Sanofi)
21.3.19.1. Overview
21.3.19.2. Product Portfolio
21.3.19.3. Key Financials
21.3.19.4. Sales Footprint
21.3.19.5. Strategy Overview
21.3.19.5.1. Marketing Strategy
21.3.19.5.2. Product Strategy
21.3.19.5.3. Channel Strategy
21.3.20. Cipla Ltd.
21.3.20.1. Overview
21.3.20.2. Product Portfolio
21.3.20.3. Key Financials
21.3.20.4. Sales Footprint
21.3.20.5. Strategy Overview
21.3.20.5.1. Marketing Strategy
21.3.20.5.2. Product Strategy
21.3.20.5.3. Channel Strategy
21.3.21. Fresenius Kabi
21.3.21.1. Overview
21.3.21.2. Product Portfolio
21.3.21.3. Key Financials
21.3.21.4. Sales Footprint
21.3.21.5. Strategy Overview
21.3.21.5.1. Marketing Strategy
21.3.21.5.2. Product Strategy
21.3.21.5.3. Channel Strategy
21.3.22. Colgate-Palmolive Company
21.3.22.1. Overview
21.3.22.2. Product Portfolio
21.3.22.3. Key Financials
21.3.22.4. Sales Footprint
21.3.22.5. Strategy Overview
21.3.22.5.1. Marketing Strategy
21.3.22.5.2. Product Strategy
21.3.22.5.3. Channel Strategy
21.3.23. EUSA Pharma
21.3.23.1. Overview
21.3.23.2. Product Portfolio
21.3.23.3. Key Financials
21.3.23.4. Sales Footprint
21.3.23.5. Strategy Overview
21.3.23.5.1. Marketing Strategy
21.3.23.5.2. Product Strategy
21.3.23.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Table 01: Global Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By ProductTable 02: Global Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Age Group
Table 03: Global Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Table 04: Global Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Region
Table 05: North America Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 06: North America Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Age Group
Table 07: North America Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Table 08: North America Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 09: Latin America Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 10: Latin America Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Age Group
Table 11: Latin America Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Table 12: Latin America Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 13: Europe Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 14: Europe Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Age Group
Table 15: Europe Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Table 16: Europe Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 17: South Asia and Pacific Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 18: South Asia and Pacific Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Age Group
Table 19: South Asia and Pacific Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Table 20: South Asia and Pacific Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 21: East Asia Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 22: East Asia Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Age Group
Table 23: East Asia Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Table 24: East Asia Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 25: Oceania Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 26: Oceania Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Age Group
Table 27: Oceania Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Table 28: Oceania Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 29: Middle East and Africa Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Product
Table 30: Middle East and Africa Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Age Group
Table 31: Middle East and Africa Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Table 32: Middle East and Africa Xerostomia (Dry Mouth) Treatment Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country